Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on inhibiting pro-inflammatory immune cells, a study shows that it is possible to restore the function of certain anti-inflammatory immune cells in a targeted manner. The results pave the way for the development of a therapy that not only works more precisely but is also associated with fewer side effects.
Quelle: ScienceDaily | Psoriasis
Titelbild/Grafik: ScienceDaily News
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Psoriasis
- Half of adults suffer from dry eyes, but most never get help
- Location matters: Belly fat compared to overall body fat more strongly linked to psoriasis risk
- Intravascular imaging can improve outcomes for complex stenting procedures in patients with high-risk calcified coronary artery disease
- PEPITEM sequence shows effects in psoriasis, comparable to steroid cream
- New treatment option for psoriasis discovered
- Plant-rich, low saturated-fat diet associated with reduced psoriasis severity
- A light-activated drug to fight psoriasis
- New study identifies key protein's role in psoriasis
- Inflammation may explain stomach problems in psoriasis sufferers
- Targeting tristetraprolin in basophils: A breakthrough in allergic inflammation treatment
